Myers Industries vs Enpro
MYE and NPO side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How MYE and NPO compare
Enpro is the larger company, worth 5.6 times as much as Myers Industries ($5.6B against $1.0B).
On earnings, Myers Industries is cheaper: it trades at 35.1× trailing earnings, against 129× for Enpro.
Myers Industries grew revenue faster over the last twelve months (24.8% versus 13.3% for Enpro).
Enpro keeps more of each dollar of sales as profit, with a net margin of 3.6% compared with 3.3% at Myers Industries.
Both pay dividends: Myers Industries yields 2.0% and Enpro 0.48%.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | MYE | NPO |
|---|---|---|
| Size and price | ||
| Market cap | $1.0B | $5.6B |
| Share price | $26.70 | $265.51 |
| Change, 1 year | 52.7% | 26.5% |
| Change, 5 years | 30.4% | 150% |
| Beta (5Y) | 0.50 | 1.18 |
| Employees | 2,200 | 4,000 |
| StockData Score | ||
| Total score | 13 | 13 |
| Valuation score | 2 (better) | 1 |
| Growth score | 3 (better) | 2 |
| Performance score | 2 (better) | 0 |
| Health score | 2 | 6 (better) |
| Dividend score | 4 | 4 |
| Valuation | ||
| P/E | 35.1× (better) | 129× |
| P/S | 1.2× (better) | 4.6× |
| P/B | 3.3× (better) | 3.5× |
| EV/EBITDA | 11.4× (better) | 21.7× |
| P/FCF | 12.4× (better) | 33.7× |
| FCF yield | 8.1% (better) | 3.0% |
| Fair value | $24.32 | $150.80 |
| Margin of safety | −9.8% (better) | −76.1% |
| Growth | ||
| Revenue growth (TTM) | 24.8% (better) | 13.3% |
| Revenue growth, 5Y average | 10.1% (better) | 7.4% |
| Net income growth (TTM) | 2.8% (better) | −47.9% |
| EPS growth (TTM) | 2.7% (better) | −48.5% |
| EPS growth, 5Y average | −1.8% (better) | −26.1% |
| Profitability | ||
| Gross margin | 33.9% | 42.8% (better) |
| Operating margin | 10.7% | 14.3% (better) |
| Net margin | 3.3% | 3.6% (better) |
| FCF margin | 9.5% | 13.6% (better) |
| Return on equity | 9.7% (better) | 2.9% |
| Return on invested capital | 12.5% (better) | 6.9% |
| Financial health | ||
| Debt / equity | 0.96 | 0.36 (better) |
| Net debt / EBITDA | 2.19 | 1.77 (better) |
| Interest coverage | – | 5.2× |
| Current ratio | 1.89 | 2.28 (better) |
| Altman Z-score | 2.82 | 4.58 (better) |
| Piotroski F-score | 6 | 6 |
| Dividends and buybacks | ||
| Dividend yield | 2.0% (better) | 0.48% |
| Payout ratio | 71.4% | 60.8% |
| Years of dividend growth | 0 | 4 (better) |
| Dividend growth, 5Y average | 0.00% | 3.6% (better) |
| Buyback yield | −0.07% | – |
| Shareholder yield | 1.9% (better) | 0.48% |
| Ownership | ||
| Held by institutions | 97.2% | 100% |
| Held by insiders | 10.3% | 0.84% |
| Insider net buying, 12 months | $0 (better) | −$2.9M |
| Short interest, % of float | 4.7% | 2.4% |
Go deeper
- MYE stock overview
- MYE income statement
- MYE valuation and score
- NPO stock overview
- NPO income statement
- NPO valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.